Current and novel treatment options for peripheral T-cell lymphoma [Interview] Journal Article
| Author: | Horwitz, S. M. |
| Article Title: | Current and novel treatment options for peripheral T-cell lymphoma [Interview] |
| Keywords: | treatment response; unclassified drug; gene mutation; prednisone; cancer recurrence; doxorubicin; note; united states; etoposide; cyclophosphamide; vincristine; cancer research; peripheral t cell lymphoma; cancer classification; romidepsin; pralatrexate; belinostat; dual specificity phosphatase; international prognostic index; randomized controlled trial (topic); clinical trial (topic); phase 2 clinical trial (topic); phase 1 clinical trial (topic); angioimmunoblastic t cell lymphoma; cancer prognosis; brentuximab vedotin; alisertib; human; duvelisib; dual specificity phosphatase 22 |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 13 |
| Issue: | 7 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2015-07-01 |
| Start Page: | 463 |
| End Page: | 466 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26353042 |
| DOI/URL: | |
| Notes: | Export Date: 2 September 2015 -- Source: Scopus |
